http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2589830-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bd4e87ecbca17f16d460ca394e60f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24fb736d99d9afcccfea154bcdfa46c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b40fabb7b84d52bd0a51ae8e01c099 |
| publicationDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2589830-C2 |
| titleOfInvention | DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL-OR N, N-DIMETHYL-)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine. Disclosed is a therapeutic dosage form for pain management, which contains 6'-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'N-spiro[cyclohexane-1,1'-pirano [3,4,b]indole]-4-amine or its physiologically acceptable salt and self-emulsifying preparation containing surfactant having hydrophilic-lipophilic balance (HLB) at least of 10 and oil, wherein oil is selected from group comprising saturated C 8 -C 14 fatty acids, unsaturated C 8 -C 18 fatty acids and their esters, mixture of saturated and unsaturated C 8 -C 14 fatty acids, triglycerides of fatty acids, esters of propylene glycol and fatty acid. Drug dosage form is intended for introduction of twice a day, once a day or less frequently. n EFFECT: technical result consists in the immediate release 6'-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'N-spiro[cyclohexane-1,1'-pirano[3,4,b]indole]-4-amine of the dosage form, in good bioavailability, despite low solubility in water and providing a long period of semi-elimination from body. n 13 cl, 1 dwg, 28 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765946-C1 |
| priorityDate | 2010-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.